The aim of this work is to create new modified dosage forms of amiodarone with triterpene glycosides in various stoichiometric ratios and to study their cytotoxicity on HeLa cells. Complexes of glycyrrhizic acid (GA) and the monoammonium salt of glycyrrhizic acid (MASGA) with amiodarone hydrochloride were obtained, characterized by certain physicochemical parameters, and studied by IR and UV spectroscopy. The supramolecular complexes were formed mainly through weak intermolecular interactions such as hydrogen bonding and ion-dipole, electrostatic, and dipole-dipole interactions. The quantitative content of GA and MASGA in the complexes was shown to affect the cytotoxicity of the drug. A modified form of amiodarone may be developed in future research and could become a promising antiarrhythmic drug.
Similar content being viewed by others
References
N. V. Medvedeva, O. M. Ipatova, Yu. D. Ivanov, et al., Biomed. Khim., 52(6), 529 – 546 (2006).
P. Yu. Fedorova, R. K. Andreson, E. K. Alekhin, et al., Med. Vestn. Bashkortostana, 4, 125 – 131 (2011).
G. A. Tolstikov, L. A. Baltina, Yu. I. Murinov, et al., Khim.-farm. Zh., 25(2), 29 – 32 (1991).
G. A. Tolstikov, L. A. Baltina, V. P. Grankina, et al., Licorice. Biodiversity, Chemistry, and Use in Medicine [in Russian], Geo, Novosibirsk (2007).
E. Tykarska, S. Sobiak, and M. Gdaniec, Cryst. Growth Des., 12, 2133 – 2137 (2012).
E. Tykarska and M. Gdaniec, Cryst. Growth Des., 13, 1301 – 1308 (2013).
Kh. A. Yuldashev, M. G. Mukhamediev, D. N. Dalimov, et al., Khim. Khim. Tekhnol., 1, 24 – 26 (2011).
A. D. Matchanov, R. S. Esanov, T. Renkawitz, et al., Materials, 15, 4197 (2022).
V. Lekar’, A. A. Nilov, S. N. Borisenko, et al., Vestn. Yuzhn. Nauchn. Tsentra Ross. Akad. Nauk, 8(2), 18 – 26 (2012).
Q. Zhang, N. E. Polyakov, Y. S. Chistyachenko, et al., Drug Delivery, 25, 198 – 209 (2018).
T. G. Tolstikova, A. G. Tolstikov, and G. A. Tolstikov, Vestn. Ross. Akad. Nauk, 77(10), 867 – 874 (2007).
M. S. Yunusov, G. A. Tolstikov, et al., RU Pat. No. 2,180,583 C1, Mar. 20, 2002.
R. H. Falk, N. Engl. J. Med., 344(14), 1067 – 1078 (2001).
E. J. Benjamin, D. Levy, S. M. Vaziri, et al., J. Am. Med. Assoc., 271(11), 840 – 844 (1994).
H. Golzari, R. D. Cebul, and R. C. Bahler, Ann. Intern. Med., 125(4), 311 – 323 (1996).
W. B. Kannel, P. A. Wolf, E. J. Benjamin, and D. Levy, Am. J. Cardiol., 82(8A), 2N-9N (1998).
A. Ruigomez, S. Johansson, M. A. Wallander, and L. A. Garcia Rodriguez, BMC Cardiovasc. Disord., 2, 5 (2002).
M. B. Iqbal, A. K. Taneja, G. Y. Lip, and M. Flather, Br. Med. J., 330(7485), 238 – 243 (2005).
G. E. Kochiadakis, N. E. Igoumenidis, M. E. Marketou, et al., Am. J. Cardiol., 81(8), 995 – 998 (1998).
D. Roy, M. Talajic, P. Dorian, et al., N. Engl. J. Med., 342(13), 913 – 920 (2000).
S. H. Chun, P. T. Sager,W. G. Stevenson, et al., Am. J. Cardiol., 76(1), 47 – 50 (1995).
C. A. Jackevicius, A. Tom, V. Essebag, et al., Am. J. Cardiol., 108, 705 – 710 (2011).
R. E. Dusman, M. S. Stanton, W. M. Miles, et al., Circulation, 82, 51 – 59 (1990).
S. B. Iskandar, B. Abi-Saleh, R. L. Keith, et al., South. Med. J., 99, 383 – 388 (2006).
L. A. Baltina, R. M. Kondratenko, S. R. Mustafina, et al., Khim.-farm. Zh., 35(1), 38 – 41 (2001).
T. G. Tolstikova, M. V. Khvostov, and A. O. Bryzgalov, Mini-Rev. Med. Chem., 9(11), 1317 – 1328 (2009).
N. E. Polyakov and T. V. Leshina, Open Conf. Proc. J., 2, 64 – 72 (2011).
L. A. Yakovishin, Doctoral Dissertation in Chemical Sciences, Sevastopol’ (2018).
B. Roy, A. Saha, A. Esterrani, et al., Soft Matter, 6, 3337 – 3345 (2010).
V. S. Kornievskaya, A. I. Kruppa, and T. V. Leshina, J. Inclusion Phenom. Macrocyclic Chem., 60(1 – 2), 123 – 130 (2008).
A. S. Vereckei, A. Blazovics, I. Gyorgy, et al., J. Cardiovasc. Electrophysiol., 4, 161 – 177 (1993).
B. Ekwall, C. Clemedson, B. Ekwall, et al., ATLA, Altern. Lab. Anim., 27, 339 – 349 (1999).
I. N. Lyapun, B. G. Andryukov, and M. P. Bynina, Mol. Genet., Microbiol. Virol., 37(4), 151 – 157 (2019).
T. Mosmann, J. Immunol. Methods, 65, 55 – 63 (1983).
M. G. Gomez Perez, L. Fourcade, M. Mateescu, and J. Paquin, Anal. Biochem., 535, 43 – 46 (2017).
K. C. da Silva Gasque, L. P. Al-Ahj, R. C. Oliveira, et al., Braz. Arch. Biol. Technol., 57(3), 381 – 385 (2014).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 12, pp. 38 – 44, December, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuldashev, K.A., Esanov, R.S., Saidullaeva, H.T. et al. Creation of Modified Forms of Amiodarone with Glycyrrhizic Acid and Its Monoammonium Salt and Study of Their Cytotoxicity on Hela Cells. Pharm Chem J 57, 1726–1731 (2024). https://doi.org/10.1007/s11094-024-03072-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-024-03072-7